Yumanity Therapeutics

Biotechnology company that transforms drug discovery for diseases caused by protein misfolding.

Launch date

2014

Employees

Market cap

Enterprise valuation

€11m (Public information from Dec 2022)

Cambridge Massachusetts (HQ)

Date	Investors	Amount	Round
-	Dolby Family Ventures Altium Capital Management	N/A	-
Feb 2016	N/A	$51.0m	Series A
Feb 2016	N/A	N/A	IPO
Jun 2018	N/A	$31.1m	Post IPO Equity
Jun 2020	N/A	$21.6m	Series C
Dec 2020	Fidelity Investments Invus	$33.6m	Late VC
Dec 2022*	Kineta	N/A	Acquisition
Total Funding		€96.6m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Yumanity Therapeutics